Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens

13 Jun 2022

Abstract excerpt

The pathogenic Clostridioides difficile and Clostridium perfringens are responsible for many health care-associated infections as well as systemic and enteric diseases. Therefore, they represent a major health threat to both humans and animals. Concerns regarding increasing antibiotic resistance (related to C. difficile and C. perfringens) have caused a surge in the pursual of novel strategies that effectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Clostridium difficile and Clostridium perfringens research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35770172
DOI: 10.3389/fmicb.2022.891790

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringensPMID 35770172Read ↗

Clostridioides difficile phage biology and applicationSemantic proximity Read ↗

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infectionSemantic proximity Read ↗

Clostridium difficile phages: still difficult?Semantic proximity Read ↗

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile SpeciesSemantic proximity Read ↗

The Evolution of Phage Therapy: A Comprehensive Review of Current Applications and Future InnovationsSemantic proximity Read ↗

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 AntimicrobialsSemantic proximity Read ↗

Phage Therapy in Gastrointestinal DiseasesSemantic proximity Read ↗

Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseasesSemantic proximity Read ↗

Phage therapy: A targeted approach to overcoming antibiotic resistanceSemantic proximity Read ↗

Treating bacterial infections with bacteriophages in the 21st centurySemantic proximity Read ↗

A Broad-Spectrum Phage Endolysin (LysCP28) Able to Remove Biofilms and Inactivate Clostridium perfringens StrainsSemantic proximity Read ↗

Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.